Pharmacological interventions for the MATRICS cognitive domains in schizophrenia: what's the evidence?

by Wilhelmina A.M. Vingerhoets, Wilhelmina A.M. Vingerhoets, Oswald J.N. Bloemen, Geor eBakker, Geor eBakker, Therese A.M.J. van Amelsvoort
Published 2013-12-01

Grey Matter Changes Associated with Heavy Cannabis Use: A Longitudinal sMRI Study.

by Laura Koenders, Janna Cousijn, Wilhelmina A M Vingerhoets, Wim van den Brink, Reinout W Wiers, Carin J Meijer, Marise W J Machielsen, Dick J Veltman, Anneke E Goudriaan, Lieuwe de Haan
Published 2016-01-01

Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion...

by Geor Bakker, Matthan W A Caan, Wilhelmina A M Vingerhoets, Fabiana da Silva-Alves, Mariken de Koning, Erik Boot, Dorien H Nieman, Lieuwe de Haan, Oswald J Bloemen, Jan Booij, Thérèse A M J van Amelsvoort
Published 2016-01-01